KAPA HyperCap Oncology Panel

Material Number: N/A

The KAPA HyperCap Oncology panel is a 214 Kb capture target panel covering the full coding sequence of 13 genes related to somatic oncology research (ATM, BRCA1, BRCA2, BRIP1, CHEK2, EGFR, ERBB2, KRAS, MET, MYCN, RAD51C, RAD51D, TP53) as well as hotspot variants across 67 relevant genes, which are found in commercially available controls. It is readily available from stock and it offers consistent quality by NGS probes QC of every lot. It is optimized to deliver high uniformity and high specificity from FFPET and cfDNA samples.

Access the information hidden in low-quality FFPE samples

  • Unlock the potential of challenging samples with the extensively optimized KAPA HyperCap FFPE DNA Workflow and the accuracy provided by the KAPA Universal UMI Adapter
  • Sequence with confidence low quantity and low quality FFPE DNA samples by achieving high percentage of error-free positions over your target (>94%)
  • Achieve uniform and deep sequencing coverage with greater that 92% of bases covered within 0.5x – 2x of the median and greater than 88% of exon bases covered by more than 300x

Achieve deep sequencing from 10 ng of cfDNA

  • Retrieve sufficient unique molecules with high percentage of duplex molecule recovery for deep and efficient cell-free DNA sequencing with the KAPA Universal UMI Adapter
  • Achieve high genome equivalent recovery rates and cover more than 97.5% of your target bases with at least 1000x from just 10 ng of cfDNA with the KAPA HyperCap cfDNA Workflow